Steakholder Foods Ltd. (MTTCF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSteakholder Foods Ltd. (MTTCF) trades at $0.001. Steakholder Foods Ltd. is an advanced deep-tech food enterprise developing innovative cultivated meat solutions using 3D bioprinting technology to produce structured cultured meat without animal slaughter. Sector: Consumer defensive.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for MTTCF: MTTCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MTTCF against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
MTTCF: the 2 scored disciplines are evenly split. Dominant signal: Ken Griffin bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Steakholder Foods Ltd. (MTTCF) Consumer Business Overview
Steakholder Foods Ltd. is an Israeli deep-tech food enterprise pioneering 3D bioprinting technology to create structured cultivated meat, aiming to provide sustainable alternatives to traditional animal agriculture. The company focuses on licensing its proprietary production systems and supplying specialized components and services to the emerging cultured meat market.
What Is the Investment Thesis for MTTCF?
Steakholder Foods Ltd. presents an investment thesis centered on its pioneering role in the cultivated meat sector through proprietary 3D bioprinting technology. A primary value driver is the potential for significant market penetration in the emerging sustainable protein industry, projected to grow substantially as consumer preferences shift towards ethical and environmentally friendly food options. The company's strategy to license its technology and supply critical components like cell lines and bioprinters positions it as an enabler for the broader cultivated meat ecosystem, potentially generating recurring revenue streams. Growth catalysts include successful regulatory approvals for cultivated meat products in key markets, which would unlock commercialization opportunities for its licensees. Furthermore, strategic partnerships with established food processors and retailers could accelerate technology adoption and scale. However, significant risks persist, including the high capital intensity of R&D, the nascent stage of market acceptance for cultivated meat, and the highly competitive landscape for alternative proteins. The company's current negative profit margin of -118740.0% and gross margin of -120.0% indicate it is in a pre-revenue or early-revenue stage, requiring substantial future investment to achieve profitability. Its OTC Other listing also implies risks related to liquidity and disclosure.
Based on FMP financials and quantitative analysis
MTTCF Key Highlights
Market capitalization of $0.00 billion, indicating a very early-stage or micro-cap valuation.
- Reported profit margin of -118740.0%, reflecting significant R&D investment and pre-revenue operational status.
- Gross margin of -120.0%, consistent with a deep-tech company in its development phase prior to commercial scale production.
- A workforce of 24 employees, focused on specialized R&D and technology development in cultivated meat.
- Headquartered in Rehovot, Israel, a hub for deep-tech and biotechnology innovation.
Who Are MTTCF's Competitors?
MTTCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| NSRGF Nestlé S.A. | $95.39 | +0.94% | $245B | 419-signal |
| DANOY Danone S.A. | $14.27 | -2.39% | $45.8B | 449-signal |
| JBS JBS N.V. | $12.62 | +0.32% | $28.0B | 945-pillar |
| GIS General Mills, Inc. | $35.96 | -3.05% | $19.2B | 545-pillar |
| KRYAF Kerry Group plc | $97.25 | 0.00% | $15.5B | 469-signal |
| MKC-V McCormick & Company | $56.53 | -2.70% | $15.2B | 469-signal |
| BMBOY Grupo Bimbo, S.A.B. de C.V. | $13.44 | -3.70% | $14.5B | 479-signal |
| SJM The J. M. Smucker Company | $120.66 | -0.34% | $12.9B | 645-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are MTTCF's Key Strengths?
Proprietary 3D bioprinting technology for structured cultivated meat.
- Focus on a high-growth, sustainable alternative protein market.
- Comprehensive B2B model including licensing, product supply, and services.
- Early mover in advanced cultivated meat manufacturing techniques.
What Are MTTCF's Weaknesses?
Negative profit and gross margins, indicating pre-revenue or early-stage commercialization.
- High capital requirements for R&D and scaling technology.
- Dependence on regulatory approvals for market entry and product commercialization.
- Small employee base (24) for a deep-tech company, potentially limiting scale.
What Could Drive MTTCF Stock Higher?
Development and refinement of proprietary 3D bioprinting technology for structured cultivated meat.
- Securing regulatory approvals for cultivated meat products in key international markets, enabling commercialization for licensees.
- Formation of strategic partnerships with established food processors or retailers for technology licensing and market penetration.
- Progress in developing and optimizing specialized cell lines, printheads, and bioreactors for cultivated meat production.
- Successful pilot programs or commercial launches of cultivated meat products by its future licensees.
What Are the Key Risks for MTTCF?
Financial-distress signal — its Altman Z-Score of -48.03 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- High capital intensity and significant R&D expenses leading to substantial negative profit and gross margins.
- Slow consumer adoption or skepticism towards cultivated meat products, limiting market growth.
- Intense competition from other cultivated meat companies, plant-based alternatives, and traditional meat producers.
- Failure to secure necessary regulatory approvals in target markets, delaying or preventing commercialization.
- Risks associated with its OTC Other listing, including limited liquidity, less stringent disclosure, and potential for price volatility.
What Are the Growth Opportunities for MTTCF?
- Expansion of Cultivated Meat Market Adoption: The global cultivated meat market is in its infancy but poised for substantial growth as regulatory frameworks mature and consumer acceptance increases. Steakholder Foods' proprietary 3D bioprinting technology, capable of producing structured meat products, positions it to capture a significant share of this expanding market. As more countries grant regulatory approval for cultivated meat, the addressable market for Steakholder Foods' licensing model and component supply will expand. This growth is anticipated over the next 5-10 years, driven by increasing investment in the sector and technological advancements that reduce production costs, making cultivated meat more competitive with traditional meat. The company's competitive advantage lies in its advanced bioprinting capabilities for complex textures.
- Technology Licensing and Partnership Model: Steakholder Foods' strategy to license its production technology and supply related products (cell lines, printheads, bioreactors) to food processors and retailers represents a scalable growth opportunity. This B2B model allows the company to penetrate various geographic markets without the need for extensive direct manufacturing infrastructure. By partnering with established food industry players, Steakholder Foods can accelerate the commercialization and distribution of cultivated meat products. This approach minimizes direct operational risk while maximizing technology adoption, with potential for revenue generation through licensing fees, equipment sales, and ongoing service contracts over the medium to long term (3-7 years).
- Development of Novel Cell Lines and Bioprinting Materials: Continuous innovation in cell line development and the creation of specialized bio-inks and scaffolding materials for 3D bioprinting offers a significant growth pathway. By developing proprietary, high-performance cell lines and print-ready materials, Steakholder Foods can enhance the quality, efficiency, and cost-effectiveness of cultivated meat production. This focus on R&D can create additional intellectual property and strengthen its competitive moat, attracting more licensees seeking superior product outcomes. This ongoing R&D effort is a continuous growth driver, with new product iterations and material advancements expected over the next 2-5 years.
- Geographic Market Expansion through Regulatory Approvals: The cultivated meat industry is highly dependent on regulatory approvals in different jurisdictions. As more countries, particularly major economic blocs like the EU, UK, and Asian markets, establish clear regulatory pathways for cultivated meat, Steakholder Foods can expand its licensing and supply operations globally. Each new market approval represents a significant opportunity to onboard new partners and increase the demand for its bioprinting technology and components. This expansion is a phased opportunity, unfolding as regulatory landscapes evolve over the next decade, with early movers gaining significant market advantage.
- Diversification into Hybrid Products and Custom Formulations: Beyond pure cultivated meat, there is a growing market for hybrid products that combine cultivated cells with plant-based ingredients, offering unique textures and nutritional profiles. Steakholder Foods' 3D bioprinting technology is adaptable to create such hybrid formulations, allowing for product diversification and catering to a broader range of consumer preferences. Furthermore, the ability to customize meat formulations for specific culinary applications or dietary needs could open new market segments. This opportunity allows for product innovation and market differentiation, with initial product development and market testing potentially occurring within the next 3-5 years.
What Are MTTCF's Competitive Advantages?
- Proprietary 3D bioprinting technology specifically designed for structured cultivated meat.
- Expertise in developing and layering differentiated stem cells and scaffolding materials.
- Intellectual property surrounding its bioprinter, cell lines, and production processes.
- First-mover advantage in advanced structured cultivated meat bioprinting.
- Comprehensive service offering including technology setup, training, and support.
What Does MTTCF Do?
Steakholder Foods Ltd., headquartered in Rehovot, Israel, operates as an advanced deep-tech food enterprise dedicated to the development of innovative cultivated meat solutions. The company's core mission revolves around producing cultured meat products that eliminate the necessity for animal slaughter, addressing growing demands for sustainable and ethical food sources. Established with a vision to revolutionize the global food industry, Steakholder Foods has engineered a sophisticated three-dimensional bioprinter. This proprietary technology is specifically designed to meticulously layer differentiated stem cells, structural scaffolding, and vital cell nutrients, thereby facilitating the creation of structured cultured meat products that mimic the texture and taste of traditional meat. This technological approach represents a significant advancement in the nascent cultivated meat sector, differentiating the company through its focus on complex, structured products rather than simpler ground meat alternatives. The company's strategic business model is centered on licensing its proprietary production technology to food processors and retailers globally. This licensing framework is complemented by the planned supply of essential related products, which include specialized cell lines, custom-designed printheads crucial for the bioprinting process, advanced bioreactors for cell cultivation, and incubators for optimal growth conditions. Beyond technology and product supply, Steakholder Foods is committed to offering a comprehensive suite of services. These services encompass technology setup and integration, thorough user training to ensure efficient operation of their systems, and ongoing technical support. These offerings are intended to be delivered both directly to clients and through strategic partnerships, enabling broad market penetration and adoption of their cultivated meat production platforms. By focusing on a B2B model, Steakholder Foods aims to become a foundational technology provider within the cultivated meat ecosystem, empowering other food companies to bring cultured meat products to market. The company's operations are exclusively based in Rehovot, Israel, from where it develops its cutting-edge solutions for a global market.
What Products and Services Does MTTCF Offer?
- Develops 3D bioprinting technology for cultivated meat production.
- Engineers a bioprinter to layer stem cells, scaffolding, and nutrients to create structured meat.
- Aims to produce cultured meat without animal slaughter.
- Intends to license its proprietary production technology to food processors and retailers.
- Supplies related products including cell lines, specialized printheads, bioreactors, and incubators.
- Offers technology setup, user training, and ongoing technical support services.
- Focuses on creating structured meat products, differentiating from ground meat alternatives.
- Operates from its base in Rehovot, Israel.
How Does MTTCF Make Money?
- Licensing proprietary 3D bioprinting technology to food processors and retailers.
- Selling specialized equipment and components, such as cell lines, printheads, bioreactors, and incubators.
- Providing technology setup, user training, and ongoing technical support services.
- Potentially earning royalties or usage fees from licensed technology.
What Industry Does MTTCF Operate In?
The cultivated meat industry is an emerging sector within the broader consumer defensive landscape, specifically targeting the packaged foods market with sustainable protein alternatives. Steakholder Foods Ltd. is positioned as a technology provider within this nascent but rapidly evolving space. Global trends indicate increasing consumer demand for ethical, environmentally friendly, and sustainable food options, driving innovation in alternative proteins. While specific market sizes for 3D bioprinted cultivated meat are still developing, the broader cultivated meat market is projected for significant growth in the coming decades, driven by advancements in biotechnology and regulatory approvals. The competitive landscape includes other cultivated meat developers, plant-based protein companies, and traditional meat producers exploring alternative protein ventures. Steakholder Foods differentiates itself by focusing on sophisticated 3D bioprinting for structured meat products, aiming to overcome texture and sensory challenges often associated with early-stage cultivated meat, rather than just ground meat alternatives. This strategic focus places it at the forefront of advanced manufacturing within the sector.
Who Are MTTCF's Key Customers?
- Food processors seeking to integrate cultivated meat production into their operations.
- Retailers interested in offering cultivated meat products under their brands.
- Strategic partners in the food industry looking for advanced meat production technologies.
- Potentially, other food tech companies requiring specialized bioprinting solutions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
Company Profile
Steakholder Foods Ltd. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Ness Ziona, IL. The company is led by CEO Arik Kaufman. MTTCF has traded publicly since 2010.
Financial Health
Steakholder Foods Ltd.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -48.03 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
Steakholder Foods Ltd. has beaten Wall Street's EPS estimate in 4 of its last 6 reported quarters — more hits than misses. Reported results have landed about 47.9% above estimates on average.
Forward Outlook
Wall Street analysts project Steakholder Foods Ltd. revenue of about $32.0M for fiscal 2026, with EPS near $-0.17.
MTTCF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Proprietary 3D bioprinting technology for structured cultivated meat.
- Focus on a high-growth, sustainable alternative protein market.
- Comprehensive B2B model including licensing, product supply, and services.
- Early mover in advanced cultivated meat manufacturing techniques.
Bear Case
- Negative profit and gross margins, indicating pre-revenue or early-stage commercialization.
- High capital requirements for R&D and scaling technology.
- Dependence on regulatory approvals for market entry and product commercialization.
- Small employee base (24) for a deep-tech company, potentially limiting scale.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
MTTCF Latest News
-
Steakholder Foods Launches Perfecta™ at Retail Outlets Across the Northeastern U.S.
Yahoo! Finance: MTTCF News · Sep 3, 2026
-
Steakholder Foods Ltd. Announces Up To $10.5 Million Private Placement
Yahoo! Finance: MTTCF News · Jul 31, 2026
-
Steakholder Foods Announces ADS Ratio Adjustment
Yahoo! Finance: MTTCF News · Jul 22, 2026
-
Steakholder Foods Commences U.S. Market Entry of Perfecta™ Premium Plant-Based Meat
Yahoo! Finance: MTTCF News · Jul 14, 2026
MTTCF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MTTCF.
Price Targets
Wall Street price target analysis for MTTCF.
MTTCF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MTTCF; grades run from A+ (80-100) to F (below 30).
Latest News
Steakholder Foods Launches Perfecta™ at Retail Outlets Across the Northeastern U.S.
Steakholder Foods Ltd. Announces Up To $10.5 Million Private Placement
Steakholder Foods Announces ADS Ratio Adjustment
Steakholder Foods Commences U.S. Market Entry of Perfecta™ Premium Plant-Based Meat
MTTCF OTC Market Information
OTC Other is the lowest tier on the OTC Markets Group platform, indicating companies that do not meet the disclosure or financial standards for OTCQX or OTCQB. These companies may not be current in their reporting or may not report to the SEC, making information less accessible. Unlike exchanges such as NYSE or NASDAQ, which have stringent listing requirements for financial health, corporate governance, and minimum share prices, OTC Other has minimal to no such requirements. This tier is often associated with penny stocks or companies with limited public information, presenting higher risks for investors due to reduced transparency and oversight.
- OTC Tier: OTC Other
- Lower liquidity and wider bid-ask spreads, making trading difficult.
- Less stringent regulatory oversight and reporting requirements compared to major exchanges.
- Potential for limited public information and transparency, hindering informed decision-making.
- Increased susceptibility to price manipulation and speculative trading due to low volume.
- Difficulty in obtaining financing due to perceived higher risk by institutional investors.
- Verify the company's latest available financial statements and audit reports.
- Research any public filings or disclosures made through OTC Markets or other sources.
- Assess the company's business operations, management team, and intellectual property claims.
- Investigate any pending litigation or regulatory actions against the company.
- Evaluate the company's cash burn rate and funding runway given its negative margins.
- Seek independent verification of product development milestones and market potential.
- Understand the share structure and potential for dilution from future capital raises.
- Active development of proprietary 3D bioprinting technology for cultivated meat.
- Stated intention to license technology and supply components, indicating a structured business model.
- Headquartered in Rehovot, Israel, a known hub for deep-tech innovation.
- Focus on a specific, emerging industry (cultivated meat) with high barriers to entry.
MTTCF Consumer Defensive Stock FAQ
Is MTTCF a good stock?
Stock Expert AI does not rate MTTCF buy, sell or hold. Steakholder Foods Ltd. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the primary financial challenges facing Steakholder Foods Ltd. given its current operational stage?
Steakholder Foods Ltd. is currently facing significant financial challenges, as evidenced by its reported profit margin of -118740.0% and a gross margin of -120.0%.
What are the key factors to evaluate for MTTCF?
Evaluate MTTCF on fundamentals, analyst consensus, and risk factors. Steakholder Foods Ltd. presents an investment thesis centered on its pioneering role in the cultivated meat sector through proprietary 3D bioprinting technology. Not financial advice.
How frequently does MTTCF data refresh on this page?
MTTCF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MTTCF's recent stock price performance?
Steakholder Foods Ltd. (MTTCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary 3D bioprinting technology for structured cultivated meat. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MTTCF overvalued or undervalued right now?
Steakholder Foods Ltd. (MTTCF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of MTTCF?
Yes, most major brokerages offer fractional shares of Steakholder Foods Ltd. (MTTCF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MTTCF's earnings and financial reports?
Steakholder Foods Ltd. (MTTCF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for MTTCF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information regarding CEO background and track record is limited to what was provided in the source data, resulting in 'Unknown' for specific details.
- Disclosure status for OTC listing is 'Unknown' as per source data.